Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Pioglitazone, Nuclear Receptors, and Aerodigestive Prevention.

Ondrey FG.

Cancer Prev Res (Phila). 2019 Oct;12(10):641-644. doi: 10.1158/1940-6207.CAPR-19-0341. Epub 2019 Sep 19.

PMID:
31537582
2.

Chemoprevention of Lung Carcinogenesis by Dietary Nicotinamide and Inhaled Budesonide.

Galbraith AR, Seabloom DE, Wuertz BR, Antonides JD, Steele VE, Wattenberg LW, Ondrey FG.

Cancer Prev Res (Phila). 2019 Feb;12(2):69-78. doi: 10.1158/1940-6207.CAPR-17-0402. Epub 2019 Jan 3.

PMID:
30606719
3.

PPARγ-Mediated p21 Induction in Aerodigestive Preneoplastic Cell Lines.

Miller WA, Wuertz BR, Ondrey FG.

Ann Otol Rhinol Laryngol. 2018 Oct;127(10):677-686. doi: 10.1177/0003489418787833. Epub 2018 Jul 26.

PMID:
30047791
4.

Pepsin: biomarker, mediator, and therapeutic target for reflux and aspiration.

Johnston N, Dettmar PW, Ondrey FG, Nanchal R, Lee SH, Bock JM.

Ann N Y Acad Sci. 2018 Dec;1434(1):282-289. doi: 10.1111/nyas.13729. Epub 2018 May 17. Review.

PMID:
29774546
5.

Effects of talactoferrin alpha on lung adenoma prevention in A/J mice June 2, 2016.

Seabloom DE, Galbraith AR, Haynes AM, Fujita AS, Antonides JD, Wuertz BR, Steele VE, Ondrey FG, Wattenberg LW.

Am J Transl Res. 2018 Mar 15;10(3):875-880. eCollection 2018.

6.

Thiazolidinediones abrogate cervical cancer growth.

Wuertz BR, Darrah L, Wudel J, Ondrey FG.

Exp Cell Res. 2017 Apr 15;353(2):63-71. doi: 10.1016/j.yexcr.2017.02.020. Epub 2017 Feb 20.

PMID:
28219679
7.

Fixed-Dose Combinations of Pioglitazone and Metformin for Lung Cancer Prevention.

Seabloom DE, Galbraith AR, Haynes AM, Antonides JD, Wuertz BR, Miller WA, Miller KA, Steele VE, Miller MS, Clapper ML, O'Sullivan MG, Ondrey FG.

Cancer Prev Res (Phila). 2017 Feb;10(2):116-123. doi: 10.1158/1940-6207.CAPR-16-0232. Epub 2017 Jan 4.

8.

Safety and Preclinical Efficacy of Aerosol Pioglitazone on Lung Adenoma Prevention in A/J Mice.

Seabloom DE, Galbraith AR, Haynes AM, Antonides JD, Wuertz BR, Miller WA, Miller KA, Steele VE, Suen CS, O'Sullivan MG, Ondrey FG.

Cancer Prev Res (Phila). 2017 Feb;10(2):124-132. doi: 10.1158/1940-6207.CAPR-16-0174. Epub 2016 Dec 19.

9.

Correlation analysis of oral lesion sizes by various standardized criteria.

Flanagan CE, Rhodus NL, Cole KA, Szabo E, Ondrey FG.

Am J Otolaryngol. 2016 Nov - Dec;37(6):502-506. doi: 10.1016/j.amjoto.2016.07.004. Epub 2016 Jul 12.

10.

PPARγ targeted oral cancer treatment and additional utility of genomics analytic techniques.

Handley N, Eide J, Taylor R, Wuertz B, Gaffney P, Ondrey F.

Laryngoscope. 2017 Apr;127(4):E124-E131. doi: 10.1002/lary.26423. Epub 2016 Nov 29.

11.

Airway reflux.

Johnston N, Ondrey F, Rosen R, Hurley BP, Gould J, Allen J, DelGaudio J, Altman KW.

Ann N Y Acad Sci. 2016 Oct;1381(1):5-13. doi: 10.1111/nyas.13080. Epub 2016 Jun 16. Review.

PMID:
27310222
12.

Functional activation of PPARγ in human upper aerodigestive cancer cell lines.

Wright SK, Wuertz BR, Harris G, Abu Ghazallah R, Miller WA, Gaffney PM, Ondrey FG.

Mol Carcinog. 2017 Jan;56(1):149-162. doi: 10.1002/mc.22479. Epub 2016 Mar 21.

13.

N-methylnitrosourea–induced carcinoma as a model for laryngeal carcinogenesis.

Caicedo-Granados E, Galbraith AR, Schachern MG, Hartle DE, Wattenberg LW, Wuertz BR, Keel S, Yueh B, Ondrey FG.

Head Neck. 2014 Dec;36(12):1802-6.

PMID:
25548813
14.

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.

Cohen EE, Karrison TG, Kocherginsky M, Mueller J, Egan R, Huang CH, Brockstein BE, Agulnik MB, Mittal BB, Yunus F, Samant S, Raez LE, Mehra R, Kumar P, Ondrey F, Marchand P, Braegas B, Seiwert TY, Villaflor VM, Haraf DJ, Vokes EE.

J Clin Oncol. 2014 Sep 1;32(25):2735-43. doi: 10.1200/JCO.2013.54.6309. Epub 2014 Jul 21.

15.

Mechanism and efficacy of sub-50-nm tenfibgen nanocapsules for cancer cell-directed delivery of anti-CK2 RNAi to primary and metastatic squamous cell carcinoma.

Unger GM, Kren BT, Korman VL, Kimbrough TG, Vogel RI, Ondrey FG, Trembley JH, Ahmed K.

Mol Cancer Ther. 2014 Aug;13(8):2018-29. doi: 10.1158/1535-7163.MCT-14-0166. Epub 2014 May 27.

16.

Quantitative proteomic analysis of oral brush biopsies identifies secretory leukocyte protease inhibitor as a promising, mechanism-based oral cancer biomarker.

Yang Y, Rhodus NL, Ondrey FG, Wuertz BR, Chen X, Zhu Y, Griffin TJ.

PLoS One. 2014 Apr 18;9(4):e95389. doi: 10.1371/journal.pone.0095389. eCollection 2014.

17.

Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma.

Sosa JA, Elisei R, Jarzab B, Balkissoon J, Lu SP, Bal C, Marur S, Gramza A, Yosef RB, Gitlitz B, Haugen BR, Ondrey F, Lu C, Karandikar SM, Khuri F, Licitra L, Remick SC.

Thyroid. 2014 Feb;24(2):232-40. doi: 10.1089/thy.2013.0078. Epub 2013 Sep 10.

PMID:
23721245
18.

Not significant but important.

Mulshine JL, Ondrey FG.

Cancer Prev Res (Phila). 2013 May;6(5):371-4. doi: 10.1158/1940-6207.CAPR-13-0106.

19.

Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancer.

Sosa JA, Balkissoon J, Lu SP, Langecker P, Elisei R, Jarzab B, Bal CS, Marur S, Gramza A, Ondrey F.

Surgery. 2012 Dec;152(6):1078-87. doi: 10.1016/j.surg.2012.08.036. Review.

PMID:
23158178
20.

Id2 regulates the proliferation of squamous cell carcinoma in vitro via the NF-κB/Cyclin D1 pathway.

Wang C, Chen Q, Hamajima Y, Sun W, Zheng YQ, Hu XH, Ondrey FG, Lin JZ.

Chin J Cancer. 2012 Sep;31(9):430-9. doi: 10.5732/cjc.011.10454. Epub 2012 Jul 26.

21.

A comparison of screening methods in two early phase oral leukoplakia clinical trials.

Rosas RR, Cole KA, Darrah L, Rohrer MD, Rhodus NL, Ondrey FG.

Oral Dis. 2012 Oct;18(7):720-3. doi: 10.1111/j.1601-0825.2012.01934.x. Epub 2012 Apr 24.

22.

Enforced expression of nuclear factor kappa B in p53 deficient keratinocytes induces cell cycle, angiogenic potential and tumorigenesis.

Caicedo-Granados EE, Wuertz BR, Ondrey FG.

Oral Oncol. 2012 Apr;48(4):303-10. doi: 10.1016/j.oraloncology.2011.11.008. Epub 2011 Dec 3.

PMID:
22143006
23.

The effect of indomethacin on paclitaxel sensitivity and apoptosis in oral squamous carcinoma cells: the role of nuclear factor-κB inhibition.

Caicedo-Granados EE, Wuertz BR, Marker PH, Lee GS, Ondrey FG.

Arch Otolaryngol Head Neck Surg. 2011 Aug;137(8):799-805. doi: 10.1001/archoto.2011.131.

PMID:
21844414
24.

Tobacco carcinogen mediated up-regulation of AP-1 dependent pro-angiogenic cytokines in head and neck carcinogenesis.

Swenson WG, Wuertz BR, Ondrey FG.

Mol Carcinog. 2011 Sep;50(9):668-79. doi: 10.1002/mc.20775. Epub 2011 Apr 7.

PMID:
21480395
25.

Interleukin-8 production in response to tumor necrosis factor-alpha by cholesteatoma keratinocytes in cell culture.

Hilton CW, Ondrey FG, Wuertz BR, Levine SC.

Laryngoscope. 2011 Feb;121(2):372-4. doi: 10.1002/lary.21352. Epub 2011 Jan 13.

PMID:
21271591
26.

The role of inhibitor of DNA-binding (Id1) in hyperproliferation of keratinocytes: the pathological basis for middle ear cholesteatoma from chronic otitis media.

Hamajima Y, Komori M, Preciado DA, Choo DI, Moribe K, Murakami S, Ondrey FG, Lin J.

Cell Prolif. 2010 Oct;43(5):457-63. doi: 10.1111/j.1365-2184.2010.00695.x.

27.

Conference Report: Eighth Annual AACR International Conference on Frontiers in Cancer Prevention Research.

Brewster AM, Patterson SL, Forman MR, Hughes-Halbert C, Limburg PJ, Ondrey FG, Paskett ED, Wetter DW, Hawk ET.

Cancer Prev Res (Phila). 2010 Aug;3(8):1044-8. doi: 10.1158/1940-6207.CAPR-10-0141. Epub 2010 Jul 27.

28.

Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions.

de Jong EP, Xie H, Onsongo G, Stone MD, Chen XB, Kooren JA, Refsland EW, Griffin RJ, Ondrey FG, Wu B, Le CT, Rhodus NL, Carlis JV, Griffin TJ.

PLoS One. 2010 Jun 17;5(6):e11148. doi: 10.1371/journal.pone.0011148.

29.

Cigarette smoke condensate induces nuclear factor kappa-b activity and proangiogenic growth factors in aerodigestive cells.

Rohrer J, Wuertz BR, Ondrey F.

Laryngoscope. 2010 Aug;120(8):1609-13. doi: 10.1002/lary.20972.

PMID:
20564670
30.

A metaproteomic analysis of the human salivary microbiota by three-dimensional peptide fractionation and tandem mass spectrometry.

Rudney JD, Xie H, Rhodus NL, Ondrey FG, Griffin TJ.

Mol Oral Microbiol. 2010 Feb;25(1):38-49. doi: 10.1111/j.2041-1014.2009.00558.x.

31.

Exons 19 and 21 of epidermal growth factor receptor are highly conserved in squamous cell cancer of the head and neck.

Carlson M, Wuertz B, Lin J, Taylor R, Ondrey F.

Int J Otolaryngol. 2009;2009:649615. doi: 10.1155/2009/649615. Epub 2010 Jan 5.

32.

Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways.

Lin J, Guan Z, Wang C, Feng L, Zheng Y, Caicedo E, Bearth E, Peng JR, Gaffney P, Ondrey FG.

Clin Cancer Res. 2010 Jan 1;16(1):77-87. doi: 10.1158/1078-0432.CCR-08-2362. Epub 2009 Dec 22.

33.

Expression of fibroblast growth factor binding protein in head and neck cancer.

Li W, Wang C, Juhn SK, Ondrey FG, Lin J.

Arch Otolaryngol Head Neck Surg. 2009 Sep;135(9):896-901. doi: 10.1001/archoto.2009.121.

34.

The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Juhn SK, Jung MK, Hoffman MD, Drew BR, Preciado DA, Sausen NJ, Jung TT, Kim BH, Park SY, Lin J, Ondrey FG, Mains DR, Huang T.

Clin Exp Otorhinolaryngol. 2008 Sep;1(3):117-38. doi: 10.3342/ceo.2008.1.3.117. Epub 2008 Sep 30.

35.

Peroxisome proliferator-activated receptor gamma pathway targeting in carcinogenesis: implications for chemoprevention.

Ondrey F.

Clin Cancer Res. 2009 Jan 1;15(1):2-8. doi: 10.1158/1078-0432.CCR-08-0326. Review.

36.

Ototoxicity after combined platinum and fractionated radiation in a novel guinea pig model.

Miller MW, Riedel G, Hoistad D, Sutherland C, Juhn SK, Adams GL, Griffin R, Ondrey FG.

Am J Otolaryngol. 2009 Jan-Feb;30(1):1-7. doi: 10.1016/j.amjoto.2007.12.003. Epub 2008 Jun 20.

PMID:
19027506
37.

TNF-alpha drives matrix metalloproteinase-9 in squamous oral carcinogenesis.

Hohberger L, Wuertz BR, Xie H, Griffin T, Ondrey F.

Laryngoscope. 2008 Aug;118(8):1395-9. doi: 10.1097/MLG.0b013e318174e09b.

PMID:
18496150
38.

Pilot randomized phase II study of celecoxib in oral premalignant lesions.

Papadimitrakopoulou VA, William WN Jr, Dannenberg AJ, Lippman SM, Lee JJ, Ondrey FG, Peterson DE, Feng L, Atwell A, El-Naggar AK, Nathan CO, Helman JI, Du B, Yueh B, Boyle JO.

Clin Cancer Res. 2008 Apr 1;14(7):2095-101. doi: 10.1158/1078-0432.CCR-07-4024.

39.

Presence of otitis media with effusion and its risk factors affect serum cytokine profile in children.

Johnston BN, Preciado DA, Ondrey FG, Daly KA.

Int J Pediatr Otorhinolaryngol. 2008 Feb;72(2):209-14. Epub 2007 Dec 4.

PMID:
18055023
40.

A method of producing carcinoma in upper aerodigestive tree and esophagus of the Syrian golden hamster using wounding and instillation of N-methylnitrosourea.

Estensen RD, Anderson WR, Galbraith AR, Hartle DE, Jordan MM, Ondrey FG, Wattenberg LW.

Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1644-50.

41.

Inositol hexaphosphate and paclitaxel: symbiotic treatment of oral cavity squamous cell carcinoma.

Janus SC, Weurtz B, Ondrey FG.

Laryngoscope. 2007 Aug;117(8):1381-8.

PMID:
17607147
42.

Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus.

Rhodus NL, Cheng B, Ondrey F.

Mediators Inflamm. 2007;2007:19854. Epub 2007 Feb 28.

43.

Efficacy of an osmotic pump delivered, GM-CSF-based tumor vaccine in the treatment of upper aerodigestive squamous cell carcinoma in rats.

Djalilian HR, Caicedo E, Lessan K, Grami V, Le CT, Spellman SR, Pambuccian S, Hall WA, Low WC, Ondrey FG.

Cancer Immunol Immunother. 2007 Aug;56(8):1207-14. Epub 2007 Jan 12.

PMID:
17219150
44.

Id1 induces the proliferation of cochlear sensory epithelial cells via the nuclear factor-kappaB/cyclin D1 pathway in vitro.

Ozeki M, Hamajima Y, Feng L, Ondrey FG, Schlentz E, Lin J.

J Neurosci Res. 2007 Feb 15;85(3):515-24. Erratum in: J Neurosci Res. 2012 Nov;90(11):2225.

PMID:
17149750
46.

Sensorineural hearing loss in Vogt-Koyanagi-Harada syndrome.

Ondrey FG, Moldestad E, Mastroianni MA, Pikus A, Sklare D, Vernon E, Nusenblatt R, Smith J.

Laryngoscope. 2006 Oct;116(10):1873-6.

PMID:
17003710
47.

Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma.

Patel KJ, Pambuccian SE, Ondrey FG, Adams GL, Gaffney PM.

Oral Oncol. 2006 Nov;42(10):994-1004. Epub 2006 Jun 9.

PMID:
16762588
48.

Decreased hearing after combined modality therapy for head and neck cancer.

Pearson SE, Meyer AC, Adams GL, Ondrey FG.

Am J Otolaryngol. 2006 Mar-Apr;27(2):76-80.

PMID:
16500467
49.

Proinflammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone.

Rhodus NL, Cheng B, Bowles W, Myers S, Miller L, Ondrey F.

Oral Dis. 2006 Mar;12(2):112-6.

PMID:
16476030
50.

PPAR activation and decreased proliferation in oral carcinoma cells with 4-HPR.

Harris G, Ghazallah RA, Nascene D, Wuertz B, Ondrey FG.

Otolaryngol Head Neck Surg. 2005 Nov;133(5):695-701.

PMID:
16274795

Supplemental Content

Loading ...
Support Center